MENU

SYRE Spyre Therapeutics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company

Industry Biotechnology
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SYRE is expected to report earnings to fall 23.53% to -103 cents per share on February 27

Spyre Therapeutics SYRE Stock Earnings Reports
Q4'24
Est.
$-1.04
Q3'24
Missed
by $0.54
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.15
Q3'23
Missed
by $8.49
The last earnings report on November 07 showed earnings per share of -136 cents, missing the estimate of -81 cents. With 279.90K shares outstanding, the current market capitalization sits at 1.48B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

SYRE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with APGE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+3.44%
APGE - SYRE
41%
Loosely correlated
+1.86%
ACLX - SYRE
40%
Loosely correlated
-1.67%
ABSI - SYRE
38%
Loosely correlated
-13.05%
TCRX - SYRE
38%
Loosely correlated
-1.33%
MGTX - SYRE
37%
Loosely correlated
+1.91%
More